| dc.contributor.author | Oguz, Arzu | |
| dc.contributor.author | Keskin, Gul Sema Yildiran | |
| dc.contributor.author | Akcali, Zafer | |
| dc.contributor.author | Colak, Dilsen | |
| dc.contributor.author | Altundag, Ozden | |
| dc.contributor.author | Altundag, Mustafa Kadri | |
| dc.date.accessioned | 2019-08-13T12:10:23Z | |
| dc.date.accessioned | 2019-08-13T15:57:15Z | |
| dc.date.available | 2019-08-13T12:10:23Z | |
| dc.date.available | 2019-08-13T15:57:15Z | |
| dc.date.issued | 2016 | |
| dc.identifier.issn | 0732-183X | |
| dc.identifier.issn | 1527-7755 | |
| dc.identifier.uri | https://dx.doi.org/10.1200/JCO.2016.34.15_suppl.e12578 | |
| dc.identifier.uri | http://hdl.handle.net/11446/2481 | |
| dc.description | Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- JUN 03-07, 2016 -- Chicago, IL | en_US |
| dc.description | WOS: 000404665402047 | en_US |
| dc.description.abstract | … | en_US |
| dc.description.sponsorship | Amer Soc Clin Oncol | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | AMER SOC CLINICAL ONCOLOGY | en_US |
| dc.identifier.doi | 10.1200/JCO.2016.34.15_suppl.e12578 | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Combined versus sequential antracycline and taxane adjuvant regimens in triple negative breast cancer patients. | en_US |
| dc.type | conferenceObject | en_US |
| dc.relation.journal | JOURNAL OF CLINICAL ONCOLOGY | en_US |
| dc.department | DBÜ | en_US |
| dc.identifier.issue | 15 | en_US |
| dc.identifier.volume | 34 | en_US |
| dc.contributor.authorID | 0000-0003-2473-4431 | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.department-temp | Baskent Univ, Dept Med Oncol, Ankara, Turkey -- Istanbul Bilim Univ, Sch Med, Istanbul, Turkey -- Baskent Univ, Fac Med, Ankara, Turkey -- Hacettepe Univ, Inst Oncol, Ankara, Turkey | en_US |
